SLC50A1 inhibits the doxorubicin sensitivity in hepatocellular carcinoma cells through regulating the tumor glycolysis
Ganggang Wang(Fudan University), Xiaoliang Wang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 6
Related Papers
AMPK/PGC-1α and p53 modulate VDAC1 expression mediated by reduced ATP level and metabolic oxidative stress in neuronal cells
|Acta Biochimica et Biophysica Sinica|2024|12